NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Parkinson's Disease (https://www.neurotalk.org/parkinson-s-disease/)
-   -   The American Prevalence of Parkinson's disease (https://www.neurotalk.org/parkinson-s-disease/113014-american-prevalence-parkinsons-disease.html)

lindylanka 06-11-2013 03:10 PM

This map may also be useful to you: http://www.npr.org/news/graphics/201...0/44.42/-72.01

johnt 07-18-2018 04:30 AM

Added for the sake of completeness. I think the maps showing variations in prevalence across the US, in the paper by Willis et al. (2010), are more useful.

Reference:

[1] "Prevalence of Parkinson’s disease across North America"
C. Marras, J. C. Beck, J. H. Bower, E. Roberts, B Ritz, G. W. Ross, R. D. Abbott, R. Savica, S. K. Van Den Eeden, A. W. Willis & CM Tanner on behalf of the Parkinson’s Foundation P4 Group
npj Parkinson's Disease
volume 4, Article number: 21 (2018)
Prevalence of Parkinson?s disease across North America | npj Parkinson'''s Disease

John

johnt 02-05-2019 07:56 PM

Added for the sake of completeness:

Willis et al. have written another paper on the geographical prevalence of PD in the US. They find [1]:

"We identified 27,538,023 Medicare beneficiaries that met our inclusion criteria, of whom 392,214 had a PD diagnosis in 2014. ... Crude prevalence varied from 845/100,000 in Minnesota to 1781/100,000 in New York. The top five states—New York, Connecticut, Florida, Pennsylvania, and Rhode Island—contained 20.7% of all Medicare beneficiaries diagnosed with PD in our sample. After adjusting for baseline differences in race, age, and sex, New York, Illinois, Connecticut, Florida, Pennsylvania, and Rhode Island remained the states with the highest prevalence."

Reference:

[1] "State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease"
Sneha Mantri, Michelle E. Fullard, James Beck & Allison W. Willis
npj Parkinson's Disease 5, Article number: 1 (2019)
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease | npj Parkinson'''s Disease

John


All times are GMT -5. The time now is 03:32 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.